ampelopsin has been researched along with metformin in 2 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (metformin) | Trials (metformin) | Recent Studies (post-2010) (metformin) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 17,793 | 3,176 | 12,526 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Liu, S; Peng, Q; Wang, J; Zhang, Y | 1 |
| Li, X; Mou, H; Wei, L; Yang, X; Yao, Y | 1 |
2 other study(ies) available for ampelopsin and metformin
| Article | Year |
|---|---|
[Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Heart Failure; HMGB1 Protein; Male; Metformin; NF-kappa B; Rats; Rats, Sprague-Dawley | 2022 |
Dihydromyricetin promotes GLP-1 release and glucose uptake by STC-1 cells and enhances the effects of metformin upon STC-1 cells and diabetic mouse model.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Glucagon-Like Peptide 1; Glucose; Hypoglycemic Agents; Insulin; Metformin; Tea | 2023 |